Arabic Arabic English English French French German German
dark

Ginkgo Bioworks Provides Preliminary Unaudited 2021 Revenue Highlights and Business Review

Expects to meet or exceed 2021 performance targets for new cell programs, Foundry revenue, and Biosecurity revenue. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Gracell Biotechnologies Unveils Innovation Center in U.S.

Next Post

AlzeCure Holds a Digital Capital Markets Day on 18 January

Related Posts
Total
0
Share